Search Result For: targeting

Young girls skin care routine social media

Date: 2025/06/11 - 00:32

TikTok Beauty Routines May Cause Skin Allergies and Irritation, Study Finds

New research shows the potential health harms of TikTok skin care videos touting "lighter, brighter skin" marketed toward young girls ages 7 to 18. Products ranged from $168 to $500 or more per regimen and contained harsh active ingredients, which may cause skin irritation and allergies.

Psilocybin mushrooms, commonly known as magic mushrooms, growing out of a stub

Date: 2025/06/06 - 20:00

Could psilocybin help treat IBS? A new study investigates

The first clinical trial examining the effects of psilocybin, the compound in magic mushrooms, on treatment-resistant IBS suggests altering the mind may be key to helping the gut.

A photo collage of a person getting their blood pressure reading taken via a blood pressure monitoring cuff and a person holding anti-hypertensive medication pills in their hand

Date: 2025/06/02 - 19:31

Novel treatment may help treat hard-to-control hypertension, global trial shows

A novel treatment, an aldosterone synthase inhibitor, safely and consistently lowered blood pressure in individuals with uncontrolled or resistant hypertension, a global phase 3 trial showed.

Date: 2025/05/29 - 22:30

NIH scientists pioneer promising treatment for intractable cancer pain

RTX is a non-addictive pain therapy derived from a cactus-like plant.

middle-aged white woman pictured in half-shadow

Date: 2025/05/21 - 20:00

Why do some people get dementia in middle age?

Protein changes linked to RNA regulation and brain connectivity could help explain how frontotemporal dementia develops in middle age.

Date: 2025/05/19 - 22:32

Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.

Two older adults walking on the beach barefoot as one puts an arm over the other and holds their shoes in the other hand

Date: 2025/05/16 - 14:31

Drug that slows Alzheimer's is safe and effective, real-world data shows

Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, “real-world” data from people with mild Alzheimer's disease shows.

A person with gloved hands separating blood samples from a vial with a pipette

Date: 2025/05/07 - 00:31

Simple blood cholesterol test may better predict coronary artery disease risk

A new study has found that apolipoprotein B particle count and lipoprotein(a) count were critical indicators of risk for coronary artery disease related to cholesterol.

An older adult mountain biking in a forest, going down a hilly part

Date: 2025/05/07 - 00:31

Could being more active in middle age help prevent Alzheimer's disease?

Researchers have found that increasing physical activity levels around ages 45 to 65 may be linked to lower levels of beta-amyloid, which is a known biomarker for Alzheimer's disease.

Date: 2025/05/05 - 23:00

Wegovy Reduced Inflammation, Scarring in People with Serious Liver Disease

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.